Risk and Regulation Magazine 32 (Winter 2018):20-23 (2018)

Giovanni De Grandis
Norwegian University of Science and Technology
The paper discusses some of the implications of regulatory innovation in the area of advanced biological therapies and personalised medicine. Benefits, risks and trade-offs are highlighted.
Keywords Pharmaceutical regulations  Bioethics  Personalised Medicine  ATMPs  Biotechnology
Categories (categorize this paper)
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

 PhilArchive page | Other versions
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

Medical Profiling and Online Medicine: The Ethics of ‘Personalised Healthcare’ in a Consumer Age.[author unknown] - 2012 - Jahrbuch für Wissenschaft Und Ethik 16 (1):441-446.
The Ethics of Personal Genetic Profiling.Christopher Hood - 2010 - Genomics, Society and Policy 6 (1):61-65.


Added to PP index

Total views
42 ( #228,208 of 2,344,159 )

Recent downloads (6 months)
6 ( #120,670 of 2,344,159 )

How can I increase my downloads?


My notes